<DOC>
	<DOC>NCT00202956</DOC>
	<brief_summary>The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis.</brief_summary>
	<brief_title>Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.</brief_title>
	<detailed_description>The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis by a study of Randomized, Double Blind, Placebo-Controlled, Parallel Group.</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1. Postmenopausal women between the ages of 45 and 75 years with a natural menopause ≧ 6 months and serum E2 values &lt; 20 pg/ml, serum FSH values ≧ 25 mIU/mL; 2. Patients have bone mineral density ＜2.5 SD of T score at the lumbar spine (L2L4); 3. All patients must sign the informed consent form (ICF) prior to the trial. 1. Any Xray film that documents substantial scoliosis, or spinal secondary osteoporosis; 2. Any Xray film that documents bone fracture within 3 month prior to the trial. 3. Medication such as estrogen, bisphosphonates, calcitonin, fluoride, glucocorticoids, ipriflavone intake within 3 weeks prior to the trial; 4. Use of other Chinese medicine within 2 weeks prior to the trial; 5. Patients with significant renal function impairment (Creatinine&gt;2mg/dl) and liver function impairment (AST and ALT &gt; 2 x the upper limit of normal range); 6. Patients have laboratory test abnormality, which in the investigator’s opinion might confound the study; 7. Patients have severe cardiac disease, e.g. unstable angina pectoris, myocardial infarction, congestive heart failure (New York Heart Association Functional Classification III and IV); 8. Patients have life threatening disease; 9. Patients are allergic to any of the composition of Chinese medicine; 10. Significant concomitant disease or medical history that could interfere with the study as judged by the investigator;</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>